亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

張家港保稅區(qū)凱利特化工有限公司  

原料藥，醫(yī)藥中間體，精細化學品
搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
聯(lián)系方式
  • 聯(lián)系人：姚廣
  • 電話：18252995085
  • QQ：524465307
站內(nèi)搜索
 
榮譽資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 鹽酸吉非替尼184475-55-6
鹽酸吉非替尼184475-55-6
單價 面議對比
詢價 暫無
發(fā)貨 江蘇蘇州市付款后3天內(nèi)
品牌 鹽酸吉非替尼184475-55-6
型號 184475-55-6
規(guī)格 鹽酸吉非替尼184475-55-6
過期 長期有效
更新 2012-08-30 13:43
 
詳細信息
英文名: Gefitinib hydrochloride
別名:    4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline hydrochloride
產(chǎn)品名稱:鹽酸吉非替尼
4-(3-氯-4-氟苯基氨基)-7-甲氧基-6-[3-(4-嗎啉基)丙氧基]喹唑啉鹽酸鹽
分子式: C22H24ClFN4O3.HCl
分子量:483.37
CAS :184475-55-6
鹽酸吉非替尼184475-55-6
 
©2025 張家港保稅區(qū)凱利特化工有限公司 版權(quán)所有   技術(shù)支持：化工網(wǎng)   訪問量:14780  
 
主站蜘蛛池模板： | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |